Abstract
Primary gastric lymphoma is the commonest form of presentation for gastrointestinal lymphomas and the stomach is one of the most frequent sites of extranodal lymphoma. We present a review of the Princess Margaret Hospital (PMH) experience to illustrate the favorable prognosis and examine the longterm outcomes in this disease. Between 1967 and 1996, 149 consecutive patients with gastric lymphoma were treated at the PMH. The majority (122 patients) presented with diffuse large-cell lymphoma and 78 had stage I disease. In the past, the standard treatment was surgery (partial gastrectomy) followed by post-operative radiation therapy (RT; 78 patients). The overall 10-year survival was 62%. For patients who were treated with surgery and post-operative RT (operable disease) between 1967 and 1985, the 10-year rates of overall survival and cause-specific survival were 66.2% and 88%, respectively. In the past decade, combined-modality therapy with chemotherapy followed by RT was introduced for large-cell lymphoma, while RT alone was used for mucosa-associated lymphoid tissue (MALT) lymphoma. In 45 patients treated in the past decade, the overall 5-year survival was 86%, the cause-specific survival was 95.5%, and the relapse-free rate was 87.3%. These results support the view that primary gastric lymphoma is a highly curable disease. Future efforts should focus on reducing treatment morbidity, while preserving excellent results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
d’Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS (1994) Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 12:1673–1684
Rohatiner A, d’Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5:397–400
Gospodarowicz MK, Sutcliffe SB, Clark RM, Dembo AJ, Patterson BJ, Fitzpatrick PJ, Chua T, Bush RS (1990) Outcome analysis of localized gastrointestinal lymphoma treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys 19:1351–1355
Gospodarowicz MK, Bush RS, Brown TC, Chua T (1983) Curability of gastrointestinal lymphoma with combined surgery and radiation. Int J Radiat Oncol Biol Phys 9:3–9
Tondini C, Giardini R, Bozzetti F, Valagussa P, Santoro A, Bertulli R, Balzarotti M, Rocca A, Lombardi F, Ferreri AJ et al (1993) Combined modality treatment for primary gastrointestinal non-Hodgkin’s lymphoma: the Milan Cancer Institute experience (see comments). Ann Oncol 4:831–837
Taal BG, Burgers JM, van Heerde P, Hart AA, Somers R (1993) The clinical spectrum and treatment of primary non-Hodgkin’s lymphoma of the stomach (see comments). Ann Oncol 4:839–846
Maor MH, Velasquez WS, Fuller LM, Silvermintz KB (1990) Stomach conservation in stages IE and IIE gastric non-Hodgkin’s lymphoma (see comments). J Clin Oncol 8:266–271
Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group (see comments). Lancet 345:1591–1594
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori (see comments). Lancet 342:575–577
de Jong D, Boot H, van Heerde P, Hart GA, Taal BG (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112:1466–1474
Koch P, Grothaus-Pinke B, Hiddemann W, Willich N, Reers B, del Valle F, Bodenstein H, Pfreundschuh M, Moller E, Kocik J, Parwaresch R, Tiemann M (1997) Primary lymphoma of the stomach: three-year results of a prospective multicenter study. The German Multicenter Study Group on GI-NHL. Ann Oncol 8[Suppl 1]:85–88
Maor MH, North LB, Cabanillas FF, Ames AL, Hess MA, Cox JD (1998) Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. Int J Radiat Oncol Biol Phys 41:647–650
Schechter NR, Portlock CS, Yahalom J (1998) Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16:1916–1921
Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma (see comments). J Natl Cancer Inst 89:1350–1355
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gospodarowicz, M.K., Pintilie, M., Tsang, R., Patterson, B., Bezjak, A., Wells, W. (2000). Primary Gastric Lymphoma: Brief Overview of the Recent Princess Margaret Hospital Experience. In: Fischbach, W. (eds) Gastrointestinal Lymphoma. Recent Results in Cancer Research, vol 156. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57054-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-57054-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62984-6
Online ISBN: 978-3-642-57054-4
eBook Packages: Springer Book Archive